This Article Full Text Full Text (PDF) All Versions of this Article: 120/19/1903    most recent CIRCULATIONAHA.109.880385v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Beels, L. Articles by Thierens, H. PubMed PubMed Citation Articles by Beels, L. Articles by Thierens, H. Related Collections Pediatric and congenital heart disease, including cardiovascular surgery Related Articles

(Circulation. 2009;120:1903-1909.)
© 2009 American Heart Association, Inc.

Pediatric Cardiology

-H2AX Foci as a Biomarker for Patient X-Ray Exposure in Pediatric Cardiac Catheterization

Are We Underestimating Radiation Risks?

Laurence Beels, MSc; Klaus Bacher, PhD; Daniël De Wolf, MD, PhD; Joke Werbrouck, MSc; Hubert Thierens, PhD

From the University of Ghent, Departments of Basic Medical Sciences (L.B., K.B., J.W., H.T.) and Pediatrics and Genetics (D.D.W.), Gent, Belgium.

Correspondence to Laurence Beels, MSc, Ghent University, Department of Basic Medical Sciences, Proeftuinstraat 86, 9000 Gent, Belgium. E-mail Laurence.Beels{at}UGent.be

Received May 18, 2009; accepted August 24, 2009.

Background— A better knowledge of patient x-ray dose and the associated radiation risk in pediatric interventional cardiology is warranted in view of the extensive use of x-rays and the higher radiosensitivity of children. In the present study, -H2AX foci were used as a biomarker for radiation-induced effects. Patient-specific dose was assessed and radiation risks were estimated according to the linear-no-threshold model, commonly used in radiation protection, and the -H2AX foci data.

Methods and Results— In 49 pediatric patients (median age, 0.75 years) with congenital heart disease who underwent cardiac catheterization procedures, blood samples were taken before and shortly after the procedure. -H2AX foci were determined in peripheral blood T lymphocytes. In each patient, a net increase in -H2AX foci, representing DNA double-strand breaks induced by interventional x-rays, was observed. In addition, a patient-specific Monte Carlo simulation of the procedure was performed, resulting in individual blood, organ, and tissue doses. Plotting of -H2AX foci versus blood dose indicated a low-dose hypersensitivity. Median effective doses calculated according to the International Commission on Radiological Protection 60 and 103 publications are 5.6 and 6.4 mSv, respectively. The lifetime-attributable risk of cancer mortality was calculated from the linear-no-threshold model and the -H2AX foci data. This resulted in lifetime-attributable risk values of 1% and 4%, respectively, for the patient population under study.

Conclusions— -H2AX foci as a biomarker for DNA damage indicate that radiation risk estimates according to the linear-no-threshold hypothesis are possibly underestimates. Great care should be taken to minimize and optimize patient radiation exposure.

---

 

CLINICAL PERSPECTIVE

Related Articles:

Clinical Summaries
Circulation 2009 120: 1843-1844. [Extract] [Full Text]

Radiation Risk From Pediatric Cardiac Catheterization: Friendly Fire on Children With Congenital Heart Disease

Maria Grazia Andreassi
Circulation 2009 120: 1847-1849. [Extract] [Full Text]

This article has been cited by other articles:

				M. G. Andreassi Radiation Risk From Pediatric Cardiac Catheterization: Friendly Fire on Children With Congenital Heart Disease Circulation, November 10, 2009; 120(19): 1847 - 1849. [Full Text] [PDF]